Viral Research and Diagnostic Laboratories

Integration of Multiple Biomarkers Fuels Robust 12.14% CAGR in Global Cardiac Biomarkers Market Through 2028 - ResearchAndMarkets.com

Retrieved on: 
Monday, November 6, 2023
Health, Cardiology, Viral Research and Diagnostic Laboratories, Heart failure, Health care, Biomarker, Acute coronary syndrome, Prevalence, Cardiovascular disease, Creatine kinase, Splenic infarction, Research, R, CVD, Growth, Hospital, Risk assessment, ACS, Troponin, Myoglobin, Diagnosis, Medical imaging, Medical device

The global cardiac biomarkers market is projected to experience robust growth, reaching $26.43 billion by 2028, with a compound annual growth rate (CAGR) of 12.14% from 2022 to 2028.

Key Points: 
  • The global cardiac biomarkers market is projected to experience robust growth, reaching $26.43 billion by 2028, with a compound annual growth rate (CAGR) of 12.14% from 2022 to 2028.
  • Key Market Trends & Drivers:
    Integration of Multiple Cardiac Biomarkers: Healthcare professionals are increasingly combining information from various cardiac biomarkers to gain a comprehensive understanding of a patient's cardiac health.
  • Increasing R&D Activities: The market is witnessing a surge in research and development (R&D) activities focused on novel cardiac biomarkers.
  • The global cardiac biomarkers market is highly competitive, with players ranging from pharmaceutical companies and diagnostic manufacturers to biotechnology firms and research institutions.

Anticipated Surge in Global Gene Panel Market: Fuelled by Rising Prevalence of Genetic Disorders – ResearchAndMarkets.com

Retrieved on: 
Friday, July 28, 2023
Biotechnology, Health, Other Health, Pharmaceutical, Oncology, Other Science, Research, Medical Devices, General Health, Hospitals, Genetics, Science, Cardiology, Medical Supplies, Pregnancy, Prevalence, Viral Research and Diagnostic Laboratories, Arthritis, Medication, Cancer, Birth, Splenic infarction, DSM-IV codes, American Cancer Society, Disorder, Down syndrome, Incidence, Tay–Sachs disease, Investment, ACS, Patient, Risk, Birth defect, Sickle cell disease, Genetic testing, Conditional sentence, Growth, Diagnosis, WHO, Educational Testing Service, Hospital, Smoking, Family, Genetic disorder, World Health Organization, Vaccine, Pharmaceutical industry, Agriculture, Pharmacogenomics

The global gene panel market is poised for impressive growth during the forecast period, driven by the increasing prevalence of genetic disorders such as Down syndrome, sickle cell disease, Tay-Sachs disease, and others.

Key Points: 
  • The global gene panel market is poised for impressive growth during the forecast period, driven by the increasing prevalence of genetic disorders such as Down syndrome, sickle cell disease, Tay-Sachs disease, and others.
  • The demand for gene panel testing surges in response to the increasing disorders caused by genetic mutations.
  • Genetic disorders are currently prevalent in the geriatric population, significantly supporting the expansion of the gene panel market.
  • The United States leads the global gene panel market due to the growing demand for gene panel techniques in response to the rising cancer cases worldwide.

Global Infectious Disease Diagnostics Market Report 2023: Sector is Expected to Reach $49 Billion by 2030 at a CAGR of 6.5% - ResearchAndMarkets.com

Retrieved on: 
Tuesday, May 30, 2023
Infectious Diseases, Pharmaceutical, Health, Microbiology, Prevalence, HIV, Viral Research and Diagnostic Laboratories, HAI, TB, Hospital, NGS, Clifton Springs Hospital & Clinic, COVID-19, Infection, Software, MEA, Personal Software Services, Fungus, Hepatitis, Point-of-care testing, Parasitism, HPV, Diagnosis, Growth, Bacteria, POC, Laboratory, Virus, PCR, Kits, Vaccine, Medical device, Medical imaging, Disease, Immunoassay, Instrument

The Global Infectious Disease Diagnostics Market is segmented based on Product, Test, Technology, Disease, End-User, and Region.

Key Points: 
  • The Global Infectious Disease Diagnostics Market is segmented based on Product, Test, Technology, Disease, End-User, and Region.
  • Based on Technology the Infectious Disease Diagnostics Market is segmented into Immunodiagnostics, Microbiology, PCR, NGS, and INAAT.
  • The infectious disease diagnostics market is expected to grow significantly due to various drivers, such as the increasing prevalence of infectious diseases.
  • The high cost of diagnostic tests is a major restraint for the growth of the infectious disease diagnostics market.

Genetic Testing Market to Reach $28.24 Billion by 2030 - Market Size, Share, Forecasts, & Trends Analysis Report by Meticulous Research®

Retrieved on: 
Monday, March 20, 2023
Glaucoma, DNA, Ventricular septal defect, Prevalence, Impact, Viral Research and Diagnostic Laboratories, Parent, Hospital, Pharmacogenomics, COVID-19, Cancer, Down syndrome, Genetic testing, Diagnosis, Genomics, Hemoglobinopathy, Disorder, Government, PerkinElmer, Fragile X syndrome, MUFG Americas Holdings Corporation, Thermo Fisher Scientific, Patient, Laboratory, Risk, Developed country, Preimplantation genetic diagnosis, Investment, Labcorp, Consumables, Cystic fibrosis, Carrier, Hospital Clinic Manuel Quintela, Association for Molecular Pathology v. Myriad Genetics, Inc., Rare, Illumina, Inc., Geography, Pharmaceutical industry, Dietary supplement, Chromosome, Prenatal development

Genetic testing is done to look at changes in the DNA, sometimes called variants or mutations, that can lead to chronic diseases.

Key Points: 
  • Genetic testing is done to look at changes in the DNA, sometimes called variants or mutations, that can lead to chronic diseases.
  • Genetic testing is performed for different reasons, including pre-symptomatic and predictive testing, pharmacogenetics, diagnostic testing, carrier testing, prenatal testing, preimplantation testing, and newborn screening.
  • Genetic testing has applications in different areas of healthcare and has various advantages, such as determining the likelihood of parents passing the genetic mutation to their offspring.
  • Quick Buy – Genetic Testing Market Research Report: https://www.meticulousresearch.com/Checkout/33822956
    Based on end user, in 2023, the hospitals & clinics segment is expected to account for the largest share of this market.

Genetic Testing Market to Reach $28.24 Billion by 2030 - Market Size, Share, Forecasts, & Trends Analysis Report by Meticulous Research®

Retrieved on: 
Monday, March 20, 2023
Glaucoma, DNA, Ventricular septal defect, Prevalence, Impact, Viral Research and Diagnostic Laboratories, Parent, Hospital, Pharmacogenomics, COVID-19, Cancer, Down syndrome, Genetic testing, Diagnosis, Genomics, Hemoglobinopathy, Disorder, Government, PerkinElmer, Fragile X syndrome, MUFG Americas Holdings Corporation, Thermo Fisher Scientific, Patient, Laboratory, Risk, Developed country, Preimplantation genetic diagnosis, Investment, Labcorp, Consumables, Cystic fibrosis, Carrier, Hospital Clinic Manuel Quintela, Association for Molecular Pathology v. Myriad Genetics, Inc., Rare, Illumina, Inc., Geography, Pharmaceutical industry, Dietary supplement, Chromosome, Prenatal development

Genetic testing is done to look at changes in the DNA, sometimes called variants or mutations, that can lead to chronic diseases.

Key Points: 
  • Genetic testing is done to look at changes in the DNA, sometimes called variants or mutations, that can lead to chronic diseases.
  • Genetic testing is performed for different reasons, including pre-symptomatic and predictive testing, pharmacogenetics, diagnostic testing, carrier testing, prenatal testing, preimplantation testing, and newborn screening.
  • Genetic testing has applications in different areas of healthcare and has various advantages, such as determining the likelihood of parents passing the genetic mutation to their offspring.
  • Quick Buy – Genetic Testing Market Research Report: https://www.meticulousresearch.com/Checkout/33822956
    Based on end user, in 2023, the hospitals & clinics segment is expected to account for the largest share of this market.

The Worldwide Food Allergy Diagnostics & Therapeutics Industry is Expected to Reach $56.8 Billion by 2027: Increasing Incidences of Allergic Diseases Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, January 23, 2023
Food, Beverage, Other Health, Health, Retail, Pharmaceutical, Investment, Egg-fish goldfish, Emotion, Ansoff matrix, COVID-19, Milk, Market development, Geography, Porter's five forces analysis, Clifton Springs Hospital & Clinic, Impact, Therapy, SWOT, Risk, USD, Viral Research and Diagnostic Laboratories, Growth, Observation, Hospital, Medical device, Risk management, Pharmaceutical industry, Egg as food, Shellfish

The report presents a detailed Ansoff matrix analysis for the Global Food Allergy Diagnostics & Therapeutics Market.

Key Points: 
  • The report presents a detailed Ansoff matrix analysis for the Global Food Allergy Diagnostics & Therapeutics Market.
  • Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.
  • The report offers a comprehensive evaluation of the Global Food Allergy Diagnostics & Therapeutics Market.
  • The Global Food Allergy Diagnostics & Therapeutics Market is segmented based on Product Type, Source, End-user, and Geography.

VR in Healthcare Market is expected to display a steady growth of 35% due to the rise in research & development activities for new technologies | UnivDatos Market Insights

Retrieved on: 
Monday, February 20, 2023
EON, Commerce, Sony, Virtual reality, Science, Health, Defense Institute, CAE Inc., National Institutes of Health, Hospital, Government, Diagnosis, Pain, HTC, Rehabilitation, Hardware, Education, Pressure, Shock, Research, Pain management, DSM-IV codes, Wilford Hall Ambulatory Surgical Center, USD, EON Reality, Growth, Component, Viral Research and Diagnostic Laboratories, Environment, Surgeon, COVID-19, SAMSUNG, Cancer, Research Diagnostic Criteria, Medical device, Pharmaceutical industry, VR, Software, NOIDA

The VR in healthcare market report has been aggregated by collecting informative data on various dynamics such as market drivers, restraints, and opportunities.

Key Points: 
  • The VR in healthcare market report has been aggregated by collecting informative data on various dynamics such as market drivers, restraints, and opportunities.
  • This innovative report makes use of several analyses to get a closer outlook on the VR in healthcare market.
  • The VR in healthcare market report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth.
  • Furthermore, this statistical market research repository examines and estimates the VR in healthcare market at the global and regional levels.

VR in Healthcare Market is expected to display a steady growth of 35% due to the rise in research & development activities for new technologies | UnivDatos Market Insights

Retrieved on: 
Monday, February 20, 2023
EON, Commerce, Sony, Virtual reality, Science, Health, Defense Institute, CAE Inc., National Institutes of Health, Hospital, Government, Diagnosis, Pain, HTC, Rehabilitation, Hardware, Education, Pressure, Shock, Research, Pain management, DSM-IV codes, Wilford Hall Ambulatory Surgical Center, USD, EON Reality, Growth, Component, Viral Research and Diagnostic Laboratories, Environment, Surgeon, COVID-19, SAMSUNG, Cancer, Research Diagnostic Criteria, Medical device, Pharmaceutical industry, VR, Software, NOIDA

The VR in healthcare market report has been aggregated by collecting informative data on various dynamics such as market drivers, restraints, and opportunities.

Key Points: 
  • The VR in healthcare market report has been aggregated by collecting informative data on various dynamics such as market drivers, restraints, and opportunities.
  • This innovative report makes use of several analyses to get a closer outlook on the VR in healthcare market.
  • The VR in healthcare market report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth.
  • Furthermore, this statistical market research repository examines and estimates the VR in healthcare market at the global and regional levels.

Single Cell Analysis Market To Reach USD 13.62 Billion by 2031, Growing at a CAGR of 17.8%| Valuates Reports

Retrieved on: 
Thursday, February 9, 2023
DNA, B cell, Polymerase chain reaction, Medicine, Flow cytometry, Molecular biology, TME, DNA sequencing, Diagnosis, Mass spectrometry, NGS, PCR, Medication, Stem, Neurology, Test management, Oncology, Single-cell analysis, Incidence, Escape Room, RNA, Cell, Research, Analysis, Tumor microenvironment, USD, RNA-Seq, Immune system, Consumables, Growth, IVF, Viral Research and Diagnostic Laboratories, CELL, Genomics, Neoplasm, Environment, Prevalence, COVID-19, Hospital, Cancer, Gene expression, Pharmaceutical industry, Fine chemical, Vaccine, Medical imaging, Biotechnology, Immunology

The global Single Cell Analysis market size was valued at USD 2.64 billion in 2021, and is projected to reach USD 13.62 billion by 2031, growing at a CAGR of 17.8% from 2022 to 2031.

Key Points: 
  • The global Single Cell Analysis market size was valued at USD 2.64 billion in 2021, and is projected to reach USD 13.62 billion by 2031, growing at a CAGR of 17.8% from 2022 to 2031.
  • Additionally, the rise in customized medicine research, the expansion of stem cell research, and the rise in cancer prevalence all contribute to the growth of the single cell analysis market.
  • This factor is expected to drive the growth of the single cell analysis market.
  • SINGLE CELL ANALYSIS MARKET SHARE ANALYSIS:
    The single cell analysis market is segmented into consumables and instruments based on product.

Single Cell Analysis Market To Reach USD 13.62 Billion by 2031, Growing at a CAGR of 17.8%| Valuates Reports

Retrieved on: 
Thursday, February 9, 2023
DNA, B cell, Polymerase chain reaction, Medicine, Flow cytometry, Molecular biology, TME, DNA sequencing, Diagnosis, Mass spectrometry, NGS, PCR, Medication, Stem, Neurology, Test management, Oncology, Single-cell analysis, Incidence, Escape Room, RNA, Cell, Research, Analysis, Tumor microenvironment, USD, RNA-Seq, Immune system, Consumables, Growth, IVF, Viral Research and Diagnostic Laboratories, CELL, Genomics, Neoplasm, Environment, Prevalence, COVID-19, Hospital, Cancer, Gene expression, Pharmaceutical industry, Fine chemical, Vaccine, Medical imaging, Biotechnology, Immunology

The global Single Cell Analysis market size was valued at USD 2.64 billion in 2021, and is projected to reach USD 13.62 billion by 2031, growing at a CAGR of 17.8% from 2022 to 2031.

Key Points: 
  • The global Single Cell Analysis market size was valued at USD 2.64 billion in 2021, and is projected to reach USD 13.62 billion by 2031, growing at a CAGR of 17.8% from 2022 to 2031.
  • Additionally, the rise in customized medicine research, the expansion of stem cell research, and the rise in cancer prevalence all contribute to the growth of the single cell analysis market.
  • This factor is expected to drive the growth of the single cell analysis market.
  • SINGLE CELL ANALYSIS MARKET SHARE ANALYSIS:
    The single cell analysis market is segmented into consumables and instruments based on product.